Novartis "buy"

15.08.06 - Dresdner Kleinwort Wasser.

LONDON, August 15 (newratings.com) - Analysts at Dresdner Kleinwort maintain their "buy" rating on Novartis (NOVN). The target price is set to CHF80.

In a research note published this morning, the analysts mention that the company?s shares provide an attractive investment opportunity, with a reasonable growth mix and limited downside risk. The analysts express their optimism regarding the performance of the Sandoz division?s longer term potential. The company?s growth going forward is likely to be driven by economies of scale and higher-margin generics, Dresdner Kleinwort adds.